FDA Orders Name Change for Maalox Total Relief

The Food and Drug Administration says Maalox Total Relief contains potent drug ingredients that can cause internal bleeding. The anti-diarrhea medication is often confused with traditional Maalox, a gentler anti-acid formula.

The FDA says manufacturer Novartis will rename Maalox Total Relief and change its packaging to avoid confusion.

The medication contains ingredients similar to aspirin, which can exacerbate bleeding in patients with stomach ulcers and blood clotting problems.

Novartis will also conduct an educational campaign on the differences between Maalox products.

Comments

Add A Comment

Name:

Email:

Comment:

Please enter the word from the image into the box below.